Loading stock data…
Pacific Biosciences of California (PACB)
$1.36-0.04 (-2.86%)
Market ClosedLast close Jul 24
Pacific Biosciences of California, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Pacific Biosciences of California, Inc. in the Healthcare sector is trading at $1.36 with a market capitalization of $427M. Wall Street consensus targets $2.46 (6 analysts), implying a +80.8% move over the next 12 months. The stock is currently near its 52-week low of $1.09, remaining 20.5% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 29 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +80.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 29) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $37.18M↓ | $44.65M↑ | $38.44M↓ | $39.77M↑ | $37.15M |
| Gross Profit | $12.84M↓ | $16.57M↑ | $15.90M↑ | $14.68M↑ | -$1.37M |
| Operating Income | -$54.15M↓ | -$41.20M↓ | -$38.88M↑ | -$44.85M↑ | -$432.63M |
| Net Income | -$8.28M↑ | -$40.37M↓ | -$38.00M↑ | -$41.93M↑ | -$426.07M |
Peer Comparison
JNJUNHPFE
Fundamentals
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technol...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$427.08M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-5434.32%
Volume
Today's trading volume
7.81M
Recent News
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.36, indicating a -5.56% shift from the previous trading day.
1 Small-Cap Stock Worth Investigating and 2 That Underwhelm
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.49, signifying a -4.49% move from its prior day's close.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressures weigh on instrument demand.
Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note
Pacific Biosciences of California (PACB) closed the most recent trading day at $1.66, moving 1.19% from the previous trading session.